Brief: Avalon Globocare Announces Diagnostic Platform For Point-Of-Care Rapid Detection Of Covid-19 And Its Clinically Relevant Mutation Strains

Change Agents

08/06/2020 14:46

June 8 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE ANNOUNCES DIAGNOSTIC PLATFORM FOR
POINT-OF-CARE
RAPID DETECTION OF COVID-19 (SARS-COV-2) AND ITS CLINICALLY
RELEVANT MUTATION STRAINS
    * AVALON GLOBOCARE - ENTERED PARTNERSHIP WITH GENSKEY
MEDICAL
TECHNOLOGY CO. LTD. TO CO-DEVELOP & COMMERCIALIZE IGG/IGM,
SARS-COV-2 DETECTION SYSTEMS

Source text for Eikon:  ID:nGNX91vh8M 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))